EverGlade Insights Blog
EverGlade, a national consulting firm, has helped SonALAsense successfully secure up to $46 million in funding to develop a minimally or non-invasive ultrasound treatment to activate a compound that can destroy cancer cells. Improving Patient...
NIAID_Presolicitation_Notice_Rad_Nuc MCMs Overview of Solicitation The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and...
ARPA-H launches groundbreaking funding opportunity The Advancing Clinical Trial Readiness (ACTR) Initiative, spearheaded by ARPA-H’s Resilient Systems Office (RSO), aims to revolutionize clinical trials by developing a decentralized, efficient, and accessible infrastructure. Overview of Solicitation...
ARPA-H-SN-25-119 (1) The Advanced Research Projects Agency for Health (ARPA-H) has launched the Emerging Health Innovators (EHI) Initiative, a transformative funding opportunity aimed at empowering early-career researchers and community-based innovators to revolutionize healthcare. To support...
HHS-NIH-NIAID-BAA2025-1 The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), has released the Broad Agency Announcement (BAA) HHS-NIH-NIAID-BAA2025-1....
JBTDS_FRP_RFI_4_Nov_2024_ The U.S. Army’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) recently issued a Request for Information (RFI) regarding Full Rate Production (FRP) of the Joint Biological Tactical Detection System...